| Models Name |
Cat.No. |
Animal Type |
Disease Area |
|
Non-alcoholic steatohepatitis, Mc4r knockout/high-fat diet-induced, in mouse (C57BL/6J)
|
AB76632 |
mouse |
Non-alcoholic steatohepatitis (NASH) |
|
Non-alcoholic steatohepatitis, palmitic acid/myristic acid/high-fat diet-induced, in mouse (C57BL/6J)
|
AB76633 |
mouse |
Non-alcoholic steatohepatitis (NASH) |
|
NT-3 Growth Factor Receptor (Trk-C) activation, in mouse (C57BL/6J)
|
AB76634 |
mouse |
|
|
Nuclear Receptor Subfamily 5 Group A Member 2 (LRH-1) inhibition, in mouse (C57BL/6J)
|
AB76635 |
mouse |
|
|
Obstructive sleep apnea, high-cholesterol diet/chronic intermittent hypoxia-induced, in mouse (C57BL/6J)
|
AB76636 |
mouse |
Sleep apnea,obstructive |
|
Osteoarthritis, transgenic (Col2a1-mutated)/Lrp5 knockout/collagenase-induced, in mouse (C57BL/6J)
|
AB76637 |
mouse |
Osteoarthritis |
|
Autosomal dominant polycystic kidney disease, (Pkd1/Cdk1) conditional knockout, in mouse (C57BL/6J)
|
AB76638 |
mouse |
Polycystic kidney,autosomal dominant |
|
Autosomal dominant polycystic kidney disease, Pkd1 +/- mutated, in mouse (C57BL/6J)
|
AB76639 |
mouse |
Polycystic kidney,autosomal dominant |
|
Autosomal dominant polycystic kidney disease, Pkd1 mutated, in mouse (C57BL/6J)
|
AB76640 |
mouse |
Polycystic kidney,autosomal dominant |
|
Autosomal dominant polycystic kidney disease, Pkd2/Ttc21b conditional knockout, in mouse (C57BL/6J)
|
AB76641 |
mouse |
Polycystic kidney,autosomal dominant |